The liver plays a central and complex role in health, being responsible for synthesis of key molecules, maintenance of metabolic balance, and detoxification processes. Liver disease is among the ten leading causes of death in the United States. Its investigation spans basic science and clinical medicine. At the University of California, San Francisco, the liver is a major focus of study in twelve Departments and two Schools (Medicine and Pharmacy) and is represented on all three University's major campuses (Moffitt-Long Hospital, San Francisco General Hospital, and the Veterans Administration Medical Center). New goals for the next period of funding include broadening the use of molecular and genetic methods. To this end, a new core facility (Molecular Biology) is proposed. In addition, two core facilities providing animal models will be merged into a single Animal Core Facility. The Center is recognized for major contributions to digestive diseases research at UCSF and, through several of its Core Facilities, serves as a national resource, providing rare animals or reagents and training in specialized techniques.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK026743-11
Application #
3101981
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Project Start
1985-07-01
Project End
1995-11-30
Budget Start
1991-04-01
Budget End
1991-11-30
Support Year
11
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Rubin, Jessica B; Hameed, Bilal; Gottfried, Michelle et al. (2018) Acetaminophen-induced Acute Liver Failure Is More Common and More Severe in Women. Clin Gastroenterol Hepatol 16:936-946
Zhang, Shanshan; Wang, Jingxiao; Wang, Haichuan et al. (2018) Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and Humans. Am J Pathol 188:995-1006
Sarkar, Monika; Lai, Jennifer C; Sawinski, Deirdre et al. (2018) Sex hormone levels by presence and severity of cirrhosis in women with chronic hepatitis C virus infection. J Viral Hepat :
Xu, Zhong; Hu, Junjie; Cao, Hui et al. (2018) Loss of Pten synergizes with c-Met to promote hepatocellular carcinoma development via mTORC2 pathway. Exp Mol Med 50:e417
Chan, Rosa; Benet, Leslie Z (2018) Evaluation of the Relevance of DILI Predictive Hypotheses in Early Drug Development: Review of In Vitro Methodologies vs BDDCS Classification. Toxicol Res (Camb) 7:358-370
Sarkar, Monika; Baffy, Gyorgy (2018) Perinatal programming of adolescent nonalcoholic fatty liver disease: A case for gender inequality? Hepatology 67:7-9
Méndez-Lagares, Gema; Lu, Ding; Chen, Connie et al. (2018) Memory T Cell Proliferation before Hepatitis C Virus Therapy Predicts Antiviral Immune Responses and Treatment Success. J Immunol 200:1124-1132
Cullaro, Giuseppe; Sarkar, Monika; Lai, Jennifer C (2018) Sex-based disparities in delisting for being ""too sick"" for liver transplantation. Am J Transplant 18:1214-1219
Liu, Xianqiong; Song, Xinhua; Zhang, Jie et al. (2018) Focal adhesion kinase activation limits efficacy of Dasatinib in c-Myc driven hepatocellular carcinoma. Cancer Med 7:6170-6181
Mehta, Neil; Guy, Jennifer; Frenette, Catherine T et al. (2018) Excellent Outcomes of Liver Transplantation Following Down-Staging of Hepatocellular Carcinoma to Within Milan Criteria: A Multicenter Study. Clin Gastroenterol Hepatol 16:955-964

Showing the most recent 10 out of 1119 publications